Brief: Aditxt Inc Provides Corporate Highlights Post Reverse Stock Split

Aditxt

27/09/2022 14:24

Sept 27 (Reuters) - Aditxt Inc  ADTX.O :
    * ADITXT INC. PROVIDES CORPORATE HIGHLIGHTS POST REVERSE
STOCK
SPLIT AND CLOSING OF $20M PUBLIC OFFERING
    * ADITXT INC - CLINICAL TRIAL APPLICATION OF ADIMUNE WILL BE
SUBMITTED IN Q1 2023, WITH AIM TO START CLINICAL STUDIES FOR
PSORIASIS IN Q3 2023

Source text for Eikon:  ID:nBw8YJdz9a 
Further company coverage:  ADTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))